XPhyto Therapeutics Corporation
- Home
- Companies
- XPhyto Therapeutics Corporation
- Products
- XPhyto - CBD:THC Oral/Sublingual Strip
XPhyto - CBD:THC Oral/Sublingual Strip
Clinical studies are planned in 2021 to demonstrate the efficient sublingual delivery of a combination of CBD and THC for Multiple Sclerosis-associated spasticity.